Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular Surgery

Loteprednol etabonate ophthalmic gel 0.38% (Lotemax(®) SM; hereafter referred to as loteprednol etabonate gel 0.38%) is a topical ophthalmic corticosteroid approved in the USA for the treatment of post-operative inflammation and pain following ocular surgery. This formulation provides improved drug...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Drug Investig
Hlavní autoři: Kang, Connie, Keam, Susan J., Shirley, Matt, Syed, Yahiya Y.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2020
Témata:
Adis Drug Evaluation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7736007/
https://ncbi.nlm.nih.gov/pubmed/32172521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-020-00899-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky